ID CDNB_HUMAN STANDARD; PRT; 198 AA. AC P46527; Q16307; Q9BUS6; DT 01-NOV-1995 (Rel. 32, Created) DT 01-NOV-1995 (Rel. 32, Last sequence update) DT 28-FEB-2003 (Rel. 41, Last annotation update) DE Cyclin-dependent kinase inhibitor 1B (Cyclin-dependent kinase DE inhibitor p27) (p27Kip1). GN CDKN1B OR KIP1. OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Primates; Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP SEQUENCE FROM N.A., AND SEQUENCE OF 28-79 AND 104-152. RC TISSUE=Kidney; RX MEDLINE=94306518; PubMed=8033212; RA Polyak K., Lee M.-H., Erdjument-Bromage H., Koff A., Roberts J.M., RA Tempst P., Massague J.; RT "Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a RT potential mediator of extracellular antimitogenic signals."; RL Cell 78:59-66(1994). RN [2] RP SEQUENCE FROM N.A. RX MEDLINE=95188144; PubMed=7882309; RA Pietenpol J.A., Bohlander S.K., Sato Y., Papadopoulos N., Liu B., RA Friedman C., Trask B.J., Roberts J.M., Kinzler K.W., Rowley J.D.; RT "Assignment of the human p27Kip1 gene to 12p13 and its analysis in RT leukemias."; RL Cancer Res. 55:1206-1210(1995). RN [3] RP SEQUENCE FROM N.A., AND VARIANTS TRP-15 AND GLY-109. RA Rieder M.J., Braun A.C., Montoya M.A., Chung M.-W., Nguyen C.P., RA Nguyen D.A., Livingston R.J., Poel C.L., Robertson P.D., RA Schackwitz W.S., Sherwood J.K., Witrak L.A., Nickerson D.A.; RL Submitted (FEB-2002) to the EMBL/GenBank/DDBJ databases. RN [4] RP SEQUENCE FROM N.A., AND VARIANT GLY-109. RC TISSUE=Cervix; RA Strausberg R.; RL Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases. RN [5] RP X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 23-106 OF COMPLEX WITH CDK2 RP AND CG2A. RX MEDLINE=96300318; PubMed=8684460; RA Russo A.A., Jeffrey P.D., Patten A.K., Massague J., Pavletich N.P.; RT "Crystal structure of the p27Kip1 cyclin-dependent-kinase inhibitor RT bound to the cyclin A-Cdk2 complex."; RL Nature 382:325-331(1996). CC -!- FUNCTION: Involved in G1 arrest. May mediate TGF beta-induced G1 CC arrest. Binds to and inhibits complexes formed by cyclin E-CDK2, CC cyclin A-CDK2, and cyclin D1-CDK4. Interaction with nucleoporin CC NUP50 is required for nuclear import and for degradation of CC phosphorylated p27Kip1 after nuclear import (By similarity). CC -!- SUBUNIT: Interacts with NUP50 (By similarity). CC -!- SUBCELLULAR LOCATION: Nuclear. CC -!- TISSUE SPECIFICITY: EXPRESSED IN ALL TISSUES TESTED. HIGHEST CC LEVELS IN SKELETAL MUSCLE, LOWEST IN LIVER AND KIDNEY. CC -!- DOMAIN: A PEPTIDE SEQUENCE CONTAINING ONLY AA 28-79 RETAINS CC SUBSTANTIAL KIP1 CYCLIN A/CDK2 INHIBITORY ACTIVITY. CC -!- SIMILARITY: THE N-TERMINAL OF CIP1 AND KIP ARE SIMILAR. CC -!- DATABASE: NAME=Atlas Genet. Cytogenet. Oncol. Haematol.; CC WWW="http://www.infobiogen.fr/services/chromcancer/Genes/CDKN1BID116.html". CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U10906; AAA20240.1; -. DR EMBL; S76988; AAD14244.1; -. DR EMBL; S76986; AAD14244.1; JOINED. DR EMBL; AF480891; AAL78041.1; -. DR EMBL; BC001971; AAH01971.1; -. DR PDB; 1JSU; 29-JUL-97. DR SWISS-2DPAGE; P46527; HUMAN. DR Genew; HGNC:1785; CDKN1B. DR MIM; 600778; -. DR InterPro; IPR003175; CDI. DR Pfam; PF02234; CDI; 1. KW Cell cycle; Nuclear protein; 3D-structure; Polymorphism. FT DOMAIN 153 169 NUCLEAR LOCALIZATION SIGNAL (POTENTIAL). FT VARIANT 15 15 R -> W (IN DBSNP:2066828). FT /FTId=VAR_011871. FT VARIANT 109 109 V -> G (IN DBSNP:2066827). FT /FTId=VAR_011872. FT CONFLICT 22 22 E -> D (IN REF. 2). SQ SEQUENCE 198 AA; 22073 MW; 1118D58901CDF3FC CRC64; MSNVRVSNGS PSLERMDARQ AEHPKPSACR NLFGPVDHEE LTRDLEKHCR DMEEASQRKW NFDFQNHKPL EGKYEWQEVE KGSLPEFYYR PPRPPKGACK VPAQESQDVS GSRPAAPLIG APANSEDTHL VDPKTDPSDS QTGLAEQCAG IRKRPATDDS STQNKRANRT EENVSDGSPN AGSVEQTPKK PGLRRRQT //